Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2025. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5472849016 | Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5472850016 | Product containing precisely ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5472851017 | Ethinyl estradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has manufactured dose form | Prolonged-release transdermal patch (dose form) | true | Inferred relationship | Some | ||
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has unit of presentation | Patch (unit of presentation) | true | Inferred relationship | Some | ||
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | Ethinylestradiol | true | Inferred relationship | Some | 1 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has presentation strength denominator unit (attribute) | hour | true | Inferred relationship | Some | 1 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has precise active ingredient | Norelgestromin (substance) | true | Inferred relationship | Some | 2 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | Norelgestromin (substance) | true | Inferred relationship | Some | 2 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Has presentation strength denominator unit (attribute) | hour | true | Inferred relationship | Some | 2 | |
| Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch | Is a | Ethinylestradiol and norelgestromin only product in transdermal dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR